CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 71 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2017. The put-call ratio across all filers is 1.49 and the average weighting 0.4%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $5,147,000 | 2.57% |
| ETF MANAGERS GROUP, LLC | 14,101,511 | $14,243,000 | 0.27% |
| Ikarian Capital, LLC | 948,526 | $968,000 | 0.07% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 289,627 | $295,000 | 0.04% |
| Platform Technology Partners | 60,000 | $61,000 | 0.03% |
| PINNACLE ASSOCIATES LTD | 966,014 | $985,000 | 0.02% |
| XTX Topco Ltd | 41,599 | $42,000 | 0.01% |
| Virtu Financial LLC | 160,380 | $164,000 | 0.01% |
| Tekla Capital Management LLC | 413,481 | $422,000 | 0.01% |
| Aries Wealth Management | 23,400 | $24,000 | 0.01% |